+80.6%
CRWD vs MRNA
+945.0%
-864.5%
-37.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.5% | +13.1% | -14.6% | -1.4% |
| 7D | -9.6% | +20.6% | -30.3% | -9.5% |
| 30D | -11.6% | +27.1% | -38.8% | -11.4% |
| 3M | +14.1% | +353.4% | -339.3% | +15.4% |
| 6M | +105.4% | +446.3% | -340.8% | +104.2% |
| YTD | +105.6% | +776.2% | -670.5% | +93.7% |
| 1Y | +80.6% | +987.9% | -907.4% | +63.4% |
| All | +80.6% | +945.0% | -864.5% | +63.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling